Theraclion SA logo

ALTHE - Theraclion SA News Story

€1.43 0.1  5.5%

Last Trade - 18/01/22

Sector
Healthcare
Size
Micro Cap
Market Cap £18.3m
Enterprise Value £19.8m
Revenue £1.22m
Position in Universe 710th / 849

BRIEF-Theraclion H1 EBIT Loss Narrows To 2.2 Million Euros

Mon 16th September, 2019 5:43pm
Sept 16 (Reuters) - THERACLION SA  ALTHER.PA :
    * THERACLION: HALF YEAR RESULTS 2019
    * H1 REVENUES INCREASED BY 52%
    * H1 NET LOSS REDUCED BY 54%
    * H1 OPERATING COSTS REDUCED BY 30%
    * H1 TOTAL REVENUES EUR 1.3 MILLION
    * H1 NET LOSS EUR 1.7 MILLION
    * H1 EBIT LOSS EUR 2.2 MILLION VERSUS LOSS EUR 4.2 MILLION
YEAR
AGO
    * CONFIRMS ITS OBJECTIVE OF ACCELERATING ITS GROWTH MOMENTUM
IN
SECOND HALF OF 2019, WITH EXPECTED SALES GROWTH BETWEEN 30% AND
50% OVERALL OVER 2019.
    * AT JUNE 30, 2019, THERACLION'S AVAILABLE CASH POSITION
AMOUNTED
TO EUR 3.1 MILLION

Source text for Eikon:  ID:nBw3wnBBka 
Further company coverage:  ALTHER.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
© Stockopedia 2022, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.